entity

Gut

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Gut: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

5Connections

19Hypotheses

1Analyses

3Outgoing

2Incoming

9Experiments

1Debates

No AI portrait yet

Wiki Pages (21)

Knowledge base pages for this entity

Canonical Page

Outgoing (3)

Target	Relation	Type	Str
Fat Absorption	involved_in	process	0.90
central nervous system	interacts_with	brain_region	0.90
OBESITY	associated_with	disease	0.80

Incoming (2)

Source	Relation	Type	Str
Brain	mediates	cell_type	0.90
Brain-to-Gut Signal	mediates	mechanism	0.85

Targeting Hypotheses (19)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming	0.888	neurodegeneration	What are the mechanisms by which gut mic
Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflam	0.789	neurodegeneration	What are the mechanisms by which gut mic
TLR4 priming is the actionable driver in: How does gut micro	0.753	neurodegeneration	How does gut microbiome dysbiosis contri
plasma LPS-binding protein separates causal from compensator	0.738	neurodegeneration	How does gut microbiome dysbiosis contri
microglial inflammasome tone defines the therapeutic window	0.720	neurodegeneration	How does gut microbiome dysbiosis contri

Gut-BBB Axis: Tributyrin/Butyrate HDAC Inhibition Epigenetic	0.712	-	Blood-brain barrier permeability changes
TLR4/MyD88/NF-κB Axis Blockade to Interrupt LPS-Mediated Gut	0.703	neurodegeneration	How do gut microbiome-derived metabolite
Leaky Gut LPS Translocation Activates Systemic TLR4/MyD88 Si	0.670	neurodegeneration	How does gut microbiome dysbiosis contri
Enhancing Vagal Cholinergic Signaling to Restore Gut-Brain A	0.669	neurodegeneration	What are the mechanisms by which gut mic
Physiological SCFAs may reduce alpha-synuclein burden primar	0.650	neurodegeneration	Do physiological concentrations of SCFAs
Gut-Brain Axis M-Cell Modulation	0.629	-	Neuroinflammation and microglial priming
H7: Enteric Nervous System Alpha-Synuclein Propagation Block	0.620	neurodegeneration	How does engineered C. butyricum cross t
Correcting Gut Microbial Dopamine Imbalance to Support Syste	0.606	neurodegeneration	What are the mechanisms by which gut mic
Gut Bacterial Metabolite-AhR Dysregulation Converts SCFA-Def	0.580	neurodegeneration	How does gut microbiome dysbiosis contri
Gut-Brain Axis Microbiome Modulation	0.557	Alzheimer's disease	Neuroinflammation and microglial priming
TLR2 Recognition of Gut-Derived Fungal and Bacterial D-Alany	0.550	neurodegeneration	How does gut microbiome dysbiosis contri
Cross-Seeding: Gut Microbiome-Derived Bacterial Curli and Fu	0.540	neurodegeneration	How does gut microbiome dysbiosis contri
Gut Barrier Permeability-α-Synuclein Axis Modulation	0.533	neurodegeneration	What are the mechanisms by which gut mic
Gut-derived butyrate reprograms microglia for amyloid cleara	0.000	Alzheimer's disease	Gut-Brain Axis Therapeutics for AD

Mentioning Analyses (1)

Scientific analyses that reference this entity

Gut-Brain Axis Therapeutics for Alzheimer's Disease

neurodegeneration | 2026-04-01 | 0 hypotheses

Experiments (9)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Model	Status	Est. Cost
Electroacupuncture ST37 treatment for DSS-induced colitis in mice	validation	colitis	0.950	mice	proposed	N/A
Resveratrol protection against renal I/R injury in diabetic rats	validation	diabetic nephropathy	0.900	streptozotocin-induced diabeti	proposed	N/A
HFD-induced cognitive dysfunction and neuroinflammation in mice	validation	diet-induced cognitive dysfunc	0.900	adult Swiss male mice	proposed	N/A
TLR expression analysis in Parkinson's disease patients	clinical	Parkinson's disease	0.850	human patients	proposed	N/A
Resveratrol effects on HK-2 cells under hypoxia/reoxygenation	exploratory	diabetic nephropathy	0.850	HK-2 cells cultured in high gl	proposed	N/A
TLR4 Activation Assay with NETs and Anti-CarP Antibodies	exploratory	rheumatoid arthritis	0.850	HEK293 TLR4 reporter cells	proposed	N/A
α7nAChR agonist treatment rescues HFD-induced memory deficits	validation	diet-induced cognitive dysfunc	0.850	HFD-fed adult Swiss male mice	proposed	N/A
TLR expression in α-synuclein overexpressing mice	validation	Parkinson's disease	0.800	mice overexpressing human α-sy	proposed	N/A
α7nAChR knockout mice show enhanced HFD sensitivity	validation	diet-induced cognitive dysfunc	0.800	Chrna7 knockout mice	proposed	N/A

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
Microglia-Mediated Neuroinflammation: A Potential Target for the Treatment of Ca [PMID:35642214]	Wang M, Pan W, Xu Y, Zhang J, Wan J, Jia	J Inflamm Res	2022	1
Astrocytic α7-nicotinic acetylcholine receptors mediate pain information process [PMID:41453579]	Teng T, Yang S, Li J, Wang H, Wu F, He Y	Neurobiology of disease	2026	0
Signal-Level Determinants of Cognitive Decline With PPIs versus H2RAs: Transport [PMID:41663888]	Saihati HAA, Ahmed BY, Mosaad RM, El-Gar	Molecular nutrition & food res	2026	0
Podocyte TLR4 deletion alleviates diabetic kidney disease through prohibiting PK [PMID:40659086]	Li Z, Tan D, Lin J, Zhang T, Liu B et al	J Adv Res	2026	0
Celastrol treatment attenuates the inflammatory response in Alzheimer's disease [PMID:40762111]	Cao F, Zhang P, Zheng Z, Wang P, Wang Y	Neurol Res	2026	0
CircCramp1l targets the miR-532-3p/HMGB1/Drp1 axis to regulate allergic rhinitis [PMID:41519399]	Zhang Y, Wang J, Song Y, Chai J, Li L et	Biochem Pharmacol	2026	0
Neuronal TLR4 upregulation activates the cGAS-STING pathway to induce ferroptosi [PMID:41702081]	Qin H, Yang L, Du J, Xu X, Chen Z et al.	Int Immunopharmacol	2026	0
2'-Fucosyllactose Alleviates Metabolic Hypertension in Mice via Gut Microbiota M [PMID:41926238]	Chen J, Liang S, Liu D, Yang S, Yan Q et	J Agric Food Chem	2026	0
Leveraging intraperitoneal delivery of toll-like receptor agonists to treat peri [PMID:41926324]	Yan H, Chia D, Ernst S, Demuytere J, Cos	Expert Opin Drug Deliv	2026	0
Small-molecule PCSK9 inhibition enhances BBB amyloid-β clearance and suppresses [PMID:41927877]	Miao J, Wang J, Zhou W, Guo J	Sci Rep	2026	0
Nicotine Suppresses Human Memory Th Cell Subsets With Preferential Effects on Ce [PMID:41928597]	Gholizadeh F, Hajiaghayi M, Rahbari N, C	Eur J Immunol	2026	0
Anti-carbamylated protein antibodies stabilize carbamylated Histone H3 to promot [PMID:41930627]	Nakabo S, Hanata N, Patino-Martinez E, H	Arthritis Rheumatol	2026	0
In silico design of a novel multi-epitope mRNA vaccine candidate for BtHKU5-CoV- [PMID:41931545]	Zheng N, Xu Y	PLoS Negl Trop Dis	2026	0
Upstream ORFs control TNFR1 abundance and tissue tolerance to TNF. [PMID:41931597]	Ma B, Lyu W, Rizk J, Han X, Kjær M et al	Sci Immunol	2026	0
Interweaving microglial senescence and gut microbiome dynamics in Alzheimer's di [PMID:41747877]	Waghmare A, Rahangdale S, Khare K, Taksa	Molecular and cellular neurosc	2026	0
Alpha 7 nicotinic acetylcholine receptor contributes to long-term cognitive reco [PMID:41270982]	Nguyen DT, Mendoza K, Hall C, Tan C, Cha	Experimental neurology	2026	0
Nanopiezoelectric 3D-Bioprinted Neural Organoid Models Epileptic Neuron-Microgli [PMID:41877549]	Chu J, Hu K, Lee WF, Xu SJ, Sun Z, Xu Y,	Nano letters	2026	0
Putative α7-selective ligands interact with α9-containing nicotinic acetylcholin [PMID:41890755]	Mobasher M, Hone AJ, Pilzecker M, Bozic	Frontiers in immunology	2026	0
The Neuroameliorative Effects of Enzymatically Modified Isoquercitrin and Sodium [PMID:41880086]	Hassouna I, Hassanein OH, El-Elaimy IA,	Neurochemical research	2026	0
Role of Pentacyclic Triterpenes in the Management of Neurological Disorders: An [PMID:41870813]	Upadhayay S	Molecular neurobiology	2026	0

Debates (1)

Multi-agent debates referencing this entity

Gut-Brain Axis Therapeutics for Alzheimer's Disease?

closed · Rounds: 4 · Score: 0.94 · 2026-04-10

Related Research

Hypotheses and analyses mentioning Gut in their description or question text

Gut-BBB Axis: Tributyrin/Butyrate HDAC Inhibition Epigenetically Restores Claudi

Score: 0.712 · unknown disease · 2026-04-26

Gut dysbiosis-driven butyrate deficit causes HDAC-mediated silencing of CLDN5 in brain endothelial cells; tributyrin pro

TLR4/MyD88/NF-κB Axis Blockade to Interrupt LPS-Mediated Gut-Brain Neuroinflamma

Score: 0.703 · neurodegeneration · 2026-04-16

**Molecular Mechanism and Rationale** The pathogenesis of Parkinson's disease (PD) involves complex interactions betwee

Leaky Gut LPS Translocation Activates Systemic TLR4/MyD88 Signaling, Driving CNS

Score: 0.670 · neurodegeneration · 2026-04-26

Dysbiosis compromises intestinal tight junctions (occludin, claudin-1, ZO-1) and reduces α-defensin production, permitti

Enhancing Vagal Cholinergic Signaling to Restore Gut-Brain Anti-Inflammatory Com

Score: 0.669 · neurodegeneration · 2026-04-02

## Mechanistic Overview Enhancing Vagal Cholinergic Signaling to Restore Gut-Brain Anti-Inflammatory Communication start

Physiological SCFAs may reduce alpha-synuclein burden primarily through a gut-fi

Score: 0.650 · neurodegeneration · 2026-04-24

Low-micromolar systemic SCFA exposure is unlikely to directly drive substantia nigra alpha-synuclein clearance, but colo

Gut-Brain Axis M-Cell Modulation

Score: 0.629 · unknown disease · 2026-04-04

## Mechanistic Overview Gut-Brain Axis M-Cell Modulation starts from the claim that modulating GP2, SPIB within the dise

H7: Enteric Nervous System Alpha-Synuclein Propagation Blocker via Gut Barrier R

Score: 0.620 · neurodegeneration · 2026-04-15

## Mechanistic Overview H7: Enteric Nervous System Alpha-Synuclein Propagation Blocker via Gut Barrier Restoration start

Correcting Gut Microbial Dopamine Imbalance to Support Systemic Dopaminergic Fun

Score: 0.606 · neurodegeneration · 2026-04-02

## Mechanistic Overview Correcting Gut Microbial Dopamine Imbalance to Support Systemic Dopaminergic Function starts fro

Gut Bacterial Metabolite-AhR Dysregulation Converts SCFA-Deficiency into IDO1-Dr

Score: 0.580 · neurodegeneration · 2026-04-26

Aryl hydrocarbon receptor (AhR), expressed in microglia, astrocytes, and neurons, normally ligates tryptophan catabolite

Gut-Brain Axis Microbiome Modulation

Score: 0.557 · Alzheimer's disease · 2026-04-04

# Gut-Brain Axis Microbiome Modulation: Preventing Neurodegeneration Through GPR43/GPR109A Signaling ## Scientific Ba

TLR2 Recognition of Gut-Derived Fungal and Bacterial D-Alanylated Lipoteichoic A

Score: 0.550 · neurodegeneration · 2026-04-26

Dysbiosis permits overgrowth of SIBO species and opportunistic fungi (Candida albicans, Malassezia) whose cell wall comp

Cross-Seeding: Gut Microbiome-Derived Bacterial Curli and Fungal Amyloid Synergi

Score: 0.540 · neurodegeneration · 2026-04-26

Commensal bacteria (E. coli, Salmonella) produce curli amyloid fibers encoded by the csg operon, while Candida and Sacch

Gut Barrier Permeability-α-Synuclein Axis Modulation

Score: 0.533 · neurodegeneration · 2026-04-02

Dysbiotic bacteria compromise intestinal barrier integrity through zonulin pathway activation, allowing bacterial antige

Gut-derived butyrate reprograms microglia for amyloid clearance via HDAC2 inhibi

Score: 0.000 · Alzheimer's disease · 2026-04-26

Specific butyrate-producing gut bacteria (e.g., Faecalibacterium, Roseburia) generate systemic butyrate that crosses the

Gut

Understanding Entity Pages

Wiki Pages (21)

Gut-Brain Axis Pathogenesis in Parkinson's Disease — Mechanism and Intervention

Gut-Brain Axis in Neurodegeneration

Gut-Microbiome-Neurodegeneration Axis

Gut Microbiome-Based Therapy for Neurodegeneration

Microbiome-Gut-Brain Axis in Alzheimer's Disease: Knowledge Gap

Microbiome Gut-Brain Axis Therapy

Section 101: Microbiome-Gut-Brain Axis in CBS/PSP

Gut-First vs Brain-First Alpha-Synuclein Propagation in Parkinson's Disease

Gut-Immune-Brain Axis Hypothesis in Parkinson's Disease

Microbiome-Gut-Brain Axis in Parkinson's Disease

Gut-First vs Brain-First Parkinson's Disease Trajectories

Gut-Brain Axis and Microbiome in Alzheimer's Disease

Section 123: Microbiome-Gut-Brain Axis Interventions for CBS/PSP